SFDA trains quality assessors on ICH quality guidelines

The Saudi Food and Drug Authority (SFDA), in cooperation with the International Council for Harmonization of Technical Requirements of Pharmaceuticals for Human Use (ICH), organized regulatory training on quality guidelines. (File)

• Saudi drug experts join global training program
• The four-week training program, which began May 1, consists of five modules

RIYADH: The Saudi Food and Drug Authority (SFDA), in cooperation with the International Council for Harmonization of Technical Requirements of Pharmaceuticals for Human Use (ICH), organized regulatory training on quality guidelines, providing assessors with in-depth knowledge and experience in the fields of chemistry, manufacturing and control.
The four-week training program, which began May 1, consists of five modules covering various disciplines, such as drug manufacturing and analyzing processes, and reviewing production stages using scientific studies.
The training is being offered by prominent international experts, including Dr. Nadine Ritter, a specialist in the field of biopharmaceuticals from the US; Dr. Mark Powell, a specialist in the field of biochemistry from the UK; and Dr. Margit Holzer, a specialist from Austria.
A group of experts from the SFDA joined them.
About 90 residents and experts from the authority, along with more than 30 residents representing a number of Arab and international regulatory authorities, also joined the program.
By organizing programs, the SFDA aims to build bridges of communication and benefit from international experts, transferring expertise internationally to improve regulatory decisions and help raise the efficiency, quality and safety of medicine worldwide.